Cargando…

Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study

BACKGROUND: Coronavirus disease 2019 (COVID-19) has triggered a global public health crisis. Proton pump inhibitors (PPIs) are one of the most commonly prescribed drugs. However, the effect of PPIs on the clinical outcomes of COVID-19 patients remains unclear. METHODS: All COVID-19 patients admitted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Haijuan, Li, Hongyu, Ma, Zhuang, Wu, Yanyan, Tang, Yufu, Meng, Hao, Yu, Hao, Peng, Chengfei, Teng, Yue, Zhang, Quanyu, Zhu, Tianyi, Zhao, Haitao, Chu, Guiyang, Tong, Zhenhua, Liu, Lu, Lu, Hui, Qi, Xingshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201367/ https://www.ncbi.nlm.nih.gov/pubmed/35721837 http://dx.doi.org/10.1177/17562848221104365

Ejemplares similares

Gastrointestinal Bleeding, but Not Other Gastrointestinal Symptoms, Is Associated With Worse Outcomes in COVID-19 Patients
por: Chen, Hongxin, et al.
Publicado: (2021)

Clinical characteristics and outcomes of COVID-19 patients with hypoxic hepatitis
por: Wu, Yanyan, et al.
Publicado: (2021)

Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests
por: Wu, Yanyan, et al.
Publicado: (2021)

Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study
por: An, Yang, et al.
Publicado: (2021)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Efficacy of Xuebijing Injection for Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Chen, Hongxin, et al.
Publicado: (2021)

Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
por: Wang, Zhenhua, et al.
Publicado: (2022)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment
por: Chen, Hao, et al.
Publicado: (2023)

High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis
por: Zhu, Zhenhua, et al.
Publicado: (2021)

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
por: Tian, Liang, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors
por: Yu, Li-Yuan, et al.
Publicado: (2017)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
por: Swaminathan, Krishnan
Publicado: (2015)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?
por: Alsalahi, Omran, et al.
Publicado: (2015)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Proton pump inhibitors induce hemolytic anemia
por: Al-Nasser, Asayil Nasser, et al.
Publicado: (2019)

When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017)

Use of proton pump inhibitors in general practice
por: Tosetti, Cesare, et al.
Publicado: (2017)

Effect of Proton Pump Inhibitors on Colorectal Cancer
por: Sasaki, Takamitsu, et al.
Publicado: (2020)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021)

The Association of Diuretics and Proton Pump Inhibitors With Chondrocalcinosis
por: Felson, David T., et al.
Publicado: (2021)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Rebuilding trust in proton pump inhibitor therapy
por: Turshudzhyan, Alla, et al.
Publicado: (2022)

Proton pump inhibitors and dementia: what association?
por: Caetano, Catarina, et al.
Publicado: (2023)

Eosinophilic Esophagitis on and off Proton Pump Inhibitor
por: Zimmer, Vincent, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sajmcg6nf99kl8svqk4jm5cbru